Search results
Results from the WOW.Com Content Network
Universal neonatal hearing screening (UNHS), which is part of early hearing detection and intervention (EHDI) programmes, refer to those services aimed at screening hearing of all newborns, regardless of the presence of a risk factor for hearing loss. UNHS is the first step in the EHDI program which indicates whether a newborn requires further ...
[8] [11] On March 11, 2009, the act was renamed as the James T. Walsh Universal Newborn Hearing Screening Program, [6] and was identified within 42 United States Code 280g-1. [6] The Act is for "the early detection, diagnosis, and treatment regarding hearing loss in newborns and infants," and includes several provisions so that these endeavors ...
From 1993 to 1996, NCHAM directed a National Consortium for Newborn Hearing Screening that resulted in over 100 hospitals in 10 states implementing newborn hearing screening programs. [ 9 ] [ 10 ] [ 11 ] From 1996 to 2000, NCHAM staff worked with newborn hearing screening programs in 35 states and provided direct assistance to over 200 ...
Newborn screening programs initially used screening criteria based largely on criteria established by JMG Wilson and F. Jungner in 1968. [6] Although not specifically about newborn population screening programs, their publication, Principles and practice of screening for disease proposed ten criteria that screening programs should meet before being used as a public health measure.
Marion Downs (January 26, 1914 – November 13, 2014) [1] was an American audiologist and professor emerita at the University of Colorado Health Sciences Center in Denver. She pioneered universal newborn hearing screening in the early 1960s and spent over 30 years advocating for its adoption in hospitals, as well as for the provision of hearing aids to infants displaying hearing loss. [2]
The following disorders are additional conditions that may be detected by screening. Many are listed as "secondary targets" by the 2005 ACMG report. [1] Some states are now screening for more than 50 congenital conditions. Many of these are rare and unfamiliar to pediatricians and other primary health care professionals. [1] Blood cell disorders
Perinatal stroke is a disease where an infant has a stroke between the 140th day of the gestation period and the 28th postpartum day, [1] affecting up to 1 in 2300 live births. [2] This disease is further divided into three subgroups, namely neonatal arterial ischemic stroke, neonatal cerebral sinovenous ischemic stroke, and presumed perinatal ...
The ABR is used for newborn hearing screening, auditory threshold estimation, intraoperative monitoring, diagnosing hearing loss type and degree, auditory nerve and brainstem lesion detection, and in development of cochlear implants. Site-of-lesion testing is sensitive to large acoustic tumors.